Robeco Institutional Asset Management B.V. Buys 1,637 Shares of Maximus, Inc. (NYSE:MMS)

Robeco Institutional Asset Management B.V. increased its holdings in Maximus, Inc. (NYSE:MMS) by 6.4% during the first quarter, HoldingsChannel reports. The institutional investor owned 27,252 shares of the health services provider’s stock after acquiring an additional 1,637 shares during the quarter. Robeco Institutional Asset Management B.V.’s holdings in Maximus were worth $1,858,000 at the end of the most recent reporting period.

Other large investors have also added to or reduced their stakes in the company. UMB Bank n.a. increased its holdings in shares of Maximus by 70.2% in the first quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock worth $41,000 after buying an additional 250 shares during the period. GAMMA Investing LLC increased its holdings in shares of Maximus by 67.1% in the first quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock worth $50,000 after buying an additional 294 shares during the period. IFP Advisors Inc increased its holdings in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider’s stock worth $59,000 after buying an additional 302 shares during the period. Farther Finance Advisors LLC increased its holdings in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider’s stock worth $61,000 after buying an additional 428 shares during the period. Finally, NBC Securities Inc. increased its holdings in shares of Maximus by 114,900.0% in the first quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider’s stock worth $78,000 after buying an additional 1,149 shares during the period. Hedge funds and other institutional investors own 97.21% of the company’s stock.

Maximus Stock Up 2.1%

NYSE MMS opened at $71.67 on Wednesday. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.84 and a quick ratio of 1.84. The stock has a market capitalization of $4.04 billion, a PE ratio of 14.25 and a beta of 0.61. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97. The business’s 50-day moving average is $70.94 and its 200 day moving average is $70.92.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.64. The company had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. Maximus’s quarterly revenue was up 1.0% on a year-over-year basis. During the same period last year, the firm earned $1.57 earnings per share. Sell-side analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.67%. Maximus’s payout ratio is 23.86%.

Analyst Ratings Changes

Separately, Wall Street Zen cut Maximus from a “buy” rating to a “hold” rating in a research note on Thursday, May 15th.

Insiders Place Their Bets

In other Maximus news, Director Gayathri Rajan sold 7,913 shares of Maximus stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total transaction of $572,742.94. Following the sale, the director directly owned 14,205 shares of the company’s stock, valued at approximately $1,028,157.90. The trade was a 35.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.60% of the company’s stock.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.